Vector Laboratories Acquires Quanta BioDesign to Continue Growth Strategy of Strengthening Development and Manufacturing Services for Life Science and Biopharma Customers

NEWARK, Calif.–(BUSINESS WIRE)–Vector Laboratories, the pioneer of innovative proteomic and glycomic research solutions, today announced the acquisition of Quanta BioDesign, the inventor of discrete polyethylene glycol (dPEG®) technology for advanced bioconjugate and payload delivery design for life science and biopharma applications. This most recent acquisition further expands Vector Laboratories’ portfolio…
Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks